Interconnection between Metabolism and Cell Cycle in Cancer

Area of Science:

• Cellular Biology
• Metabolic Regulation
• Cancer Therapeutics

Background:

• Cell cycle progression relies on cyclin-dependent kinases (CDKs) and checkpoint controls.
• Cancer cells exhibit altered metabolic pathways, notably increased glucose and glutamine uptake for biosynthesis.
• Metabolic enzymes play roles beyond energy production, influencing gene expression and cell cycle regulation.

Purpose of the Study:

• To explore the interplay between cellular metabolism and cell cycle progression in cancer.
• To investigate the nuclear functions of metabolic enzymes in regulating cell cycle and oncogene expression.
• To assess the therapeutic potential of targeting metabolic enzymes in conjunction with CDK inhibitors (CKIs).

Main Methods:

• Review of recent studies on metabolic enzyme localization and function.
• Analysis of metabolic shifts (glycolysis, glutaminolysis) during different cell cycle phases.
• Examination of nuclear translocation of enzymes like PKM2, PFKFB3, and GAPDH.
• Investigation of oncogene (c-Myc) regulation by metabolic enzymes.

Main Results:

• Inactivation of pyruvate kinase M2 (PKM2) is linked to G1 phase transcription.
• Glutamine metabolism supports DNA replication in S phase and lipid synthesis in G2 phase.
• Metabolic enzymes (PKM2, PFKFB3, GAPDH) translocate to the nucleus, regulating cell cycle and oncogene expression.
• Enhanced glycolysis and oxidative metabolism provide ATP for critical cell cycle transitions.

Conclusions:

• Metabolic enzymes are integral regulators of cell cycle progression.
• Targeting nuclear functions of metabolic enzymes offers a novel therapeutic strategy.
• Combined targeting of metabolic enzymes and CDK inhibitors (CKIs) may improve cancer treatment efficacy.